# H11-ANTIBIOTICA: Antibiotics & Resistance Engine

## Overview
H11-ANTIBIOTICA specializes in the pharmacology of antibacterial agents. It handles the structural analysis of beta-lactams, fluoroquinolones, macrolides, and other classes. It dynamically models bacterial resistance mechanisms (such as ESBL production, MRSA mecA expression, and VRE target modifications), calculates Minimum Inhibitory Concentrations (MIC), and generates antibiotic stewardship protocols.

## Core Capabilities
- **Pharmacophore Analysis**: Maps structural properties of compounds to ribosomal, cell-wall, or DNA gyrase targets.
- **Resistance Mechanism Simulation**: Predicts susceptibility breakdown due to beta-lactamases, efflux pumps, or porin channel mutations.
- **MIC Prediction**: Uses quantitative structure-activity relationship (QSAR) models adapted for distinct Gram-positive and Gram-negative profiles.
- **Stewardship & Pharmacodynamics (PK/PD)**: Optimizes dosing regimens (time-dependent vs. concentration-dependent killing) to minimize selection pressure for resistance.

## Technical Architecture
- `ResistanceMechanismAnalyzer`: Employs stochastic state models to estimate the emergence probability of resistant sub-populations during treatment.
- `QSAR_MIC_Engine`: A computational module translating molecular weight, lipophilicity, and charge into predicted MIC values.
- `StewardshipOptimizer`: An algorithmic guideline generator matching local antibiogram data to optimal empiric and targeted therapies.

## Failure Modes & Recovery
- **Pan-resistance**: If a strain exhibits resistance to all standard classes, the agent defaults to combination therapy analysis (e.g., synergistic beta-lactam/beta-lactamase inhibitor combinations).
- **Toxicity Limits**: When MIC prediction exceeds safe human Cmax, the stewardship module forces a therapeutic switch or recommends topical/localized delivery.
